Cogent Biosciences (COGT) EPS (Basic) (2017 - 2026)
Cogent Biosciences' (COGT) quarterly EPS (Basic) came in at -$0.69 in Q1 2026, down 7.92% year-on-year from -$0.74 in Q1 2025, and up 19.73% on a QoQ basis from -$0.85 in Q4 2025.
Cogent Biosciences (COGT) EPS (Basic) (2017 - 2026) Analysis & Trends
Cogent Biosciences (COGT) has 10 years of EPS (Basic) data on file, last reported at -$0.69 in Q1 2026.
- On a quarterly basis, EPS (Basic) fell 7.92% year-over-year to -$0.69 in Q1 2026; TTM through Mar 2026 was -$2.36, a 0.05% change from a year earlier, with the FY2025 full-year figure at -$8.38, down 82.76% from the prior year.
- EPS (Basic) for Q1 2026 stood at -$0.69, up from -$0.85 in the prior quarter.
- Over the last five years, EPS (Basic) for COGT reached as high as -$0.54 in Q4 2024 and fell as low as -$1.51 in Q2 2022.
- Historically, EPS (Basic) has averaged -$0.73 across 5 years, with a median of -$0.67 in 2024.
- Across the five-year window, EPS (Basic) sank 167.23% in 2022 and surged 58.12% in 2023, its largest moves.
- Year by year, EPS (Basic) stood at -$0.68 in 2022, then dropped by 8.8% to -$0.74 in 2023, then increased by 26.81% to -$0.54 in 2024, then sank by 57.57% to -$0.85 in 2025, then grew by 19.73% to -$0.69 in 2026.
- Per Business Quant data, the three most recent EPS (Basic) figures were -$0.69 in Q1 2026, -$0.85 in Q4 2025, and -$0.62 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.90 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | Cogent Biosciences | 6.45 Bn | 6.45 Bn | - | -0.69 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.69 |
| Dec 31, 2025 | -0.85 |
| Sep 30, 2025 | -0.62 |
| Jun 30, 2025 | -0.66 |
| Mar 31, 2025 | -0.64 |
| Dec 31, 2024 | -0.54 |
| Sep 30, 2024 | -0.67 |
| Jun 30, 2024 | -0.65 |
| Mar 31, 2024 | -0.66 |
| Dec 31, 2023 | -0.74 |
| Sep 30, 2023 | -0.69 |
| Jun 30, 2023 | -0.63 |
| Mar 31, 2023 | -0.61 |
| Dec 31, 2022 | -0.68 |
| Sep 30, 2022 | -0.69 |
| Jun 30, 2022 | -1.51 |
| Mar 31, 2022 | -0.80 |
| Dec 31, 2021 | -0.69 |
| Sep 30, 2021 | -0.51 |
| Jun 30, 2021 | -0.57 |